NASDAQ:OASM - Oasmia Pharmaceutical AB (publ) Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$1.00
+0.30 (1.20%)
Get New Oasmia Pharmaceutical AB (publ) Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for OASM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for OASM

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Oasmia Pharmaceutical AB (publ) in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $1.00.

This chart shows the closing price for OASM for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in Oasmia Pharmaceutical AB (publ). This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/1/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/31/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/29/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/27/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/26/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/25/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/24/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/12/2016HC WainwrightInitiated CoverageBuy$6.00N/A
9/12/2016Rodman & RenshawInitiated CoverageBuy$6.00 ➝ $6.00N/A
(Data available from 6/24/2016 forward)

Oasmia Pharmaceutical AB (publ)

Oasmia Pharmaceutical AB engages in the research and development of drugs. It formulates pharmaceutical products for ovarian and breast cancer for humans and cancer for animals. The company was founded by Julian Aleksov and Bo Cederstrand on April 15, 1988 and is headquartered in Uppsala, Sweden.
Read More

Today's Range

Now: $1.00
Low: $1.00
High: $1.00

50 Day Range

MA: $1.46
Low: $1.30
High: $1.62

52 Week Range

Now: $1.00
Low: $0.94
High: $5.70

Volume

N/A

Average Volume

98,414 shs

Market Capitalization

$74.83 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.96

Frequently Asked Questions

What sell-side analysts currently cover shares of Oasmia Pharmaceutical AB (publ)?

The following equities research analysts have issued reports on Oasmia Pharmaceutical AB (publ) in the last twelve months:
View the latest analyst ratings for OASM.

What is the current price target for Oasmia Pharmaceutical AB (publ)?

0 Wall Street analysts have set twelve-month price targets for Oasmia Pharmaceutical AB (publ) in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Oasmia Pharmaceutical AB (publ) in the next year.
View the latest price targets for OASM.

What is the current consensus analyst rating for Oasmia Pharmaceutical AB (publ)?

Oasmia Pharmaceutical AB (publ) currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for OASM.

What other companies compete with Oasmia Pharmaceutical AB (publ)?

How do I contact Oasmia Pharmaceutical AB (publ)'s investor relations team?

Oasmia Pharmaceutical AB (publ)'s physical mailing address is VALLONGATAN 1, UPPSALA V7, 75228. The company's listed phone number is (461) 850-5440 and its investor relations email address is [email protected] The official website for Oasmia Pharmaceutical AB (publ) is www.oasmia.com.